Kyle Mikson
Stock Analyst at Canaccord Genuity
(3.13)
# 1,190
Out of 5,124 analysts
120
Total ratings
41.94%
Success rate
3.05%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WGS GeneDx Holdings | Maintains: Buy | $160 → $170 | $130.06 | +30.71% | 3 | Dec 22, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $19 → $20 | $16.31 | +22.62% | 10 | Dec 22, 2025 | |
| TEM Tempus AI | Maintains: Buy | $95 → $80 | $59.05 | +35.48% | 3 | Dec 22, 2025 | |
| QTRX Quanterix | Maintains: Hold | $5 → $8 | $6.36 | +25.79% | 8 | Dec 22, 2025 | |
| QSI Quantum-Si incorporated | Maintains: Hold | $2 → $1.5 | $1.10 | +36.36% | 6 | Dec 22, 2025 | |
| NTRA Natera | Maintains: Buy | $250 → $285 | $229.09 | +24.41% | 12 | Dec 22, 2025 | |
| ILMN Illumina | Maintains: Hold | $112 → $130 | $131.16 | -0.88% | 14 | Dec 22, 2025 | |
| GH Guardant Health | Maintains: Buy | $100 → $125 | $102.14 | +22.38% | 10 | Dec 22, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $37 → $50 | $38.90 | +28.53% | 6 | Dec 22, 2025 | |
| CAI Caris Life Sciences | Maintains: Hold | $28 → $30 | $26.98 | +11.19% | 2 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $85 → $105 | $101.56 | +3.39% | 10 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $105 | $85.59 | +22.68% | 5 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $40 → $43 | $42.10 | +2.14% | 2 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $150 → $165 | $163.86 | +0.70% | 4 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $15 | $6.10 | +145.90% | 5 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $20 | $6.80 | +194.12% | 5 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.87 | +60.43% | 8 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.09 | +175.23% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3 → $2 | $0.26 | +682.47% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $0.22 | +22,182.61% | 1 | Mar 30, 2021 |
GeneDx Holdings
Dec 22, 2025
Maintains: Buy
Price Target: $160 → $170
Current: $130.06
Upside: +30.71%
10x Genomics
Dec 22, 2025
Maintains: Buy
Price Target: $19 → $20
Current: $16.31
Upside: +22.62%
Tempus AI
Dec 22, 2025
Maintains: Buy
Price Target: $95 → $80
Current: $59.05
Upside: +35.48%
Quanterix
Dec 22, 2025
Maintains: Hold
Price Target: $5 → $8
Current: $6.36
Upside: +25.79%
Quantum-Si incorporated
Dec 22, 2025
Maintains: Hold
Price Target: $2 → $1.5
Current: $1.10
Upside: +36.36%
Natera
Dec 22, 2025
Maintains: Buy
Price Target: $250 → $285
Current: $229.09
Upside: +24.41%
Illumina
Dec 22, 2025
Maintains: Hold
Price Target: $112 → $130
Current: $131.16
Upside: -0.88%
Guardant Health
Dec 22, 2025
Maintains: Buy
Price Target: $100 → $125
Current: $102.14
Upside: +22.38%
Castle Biosciences
Dec 22, 2025
Maintains: Buy
Price Target: $37 → $50
Current: $38.90
Upside: +28.53%
Caris Life Sciences
Dec 22, 2025
Maintains: Hold
Price Target: $28 → $30
Current: $26.98
Upside: +11.19%
Nov 25, 2025
Downgrades: Hold
Price Target: $85 → $105
Current: $101.56
Upside: +3.39%
Nov 17, 2025
Maintains: Buy
Price Target: $85 → $105
Current: $85.59
Upside: +22.68%
Nov 5, 2025
Maintains: Hold
Price Target: $40 → $43
Current: $42.10
Upside: +2.14%
Oct 29, 2025
Maintains: Hold
Price Target: $150 → $165
Current: $163.86
Upside: +0.70%
Oct 27, 2025
Maintains: Buy
Price Target: $11 → $15
Current: $6.10
Upside: +145.90%
Sep 19, 2025
Maintains: Buy
Price Target: $30 → $20
Current: $6.80
Upside: +194.12%
Apr 10, 2025
Maintains: Buy
Price Target: $3
Current: $1.87
Upside: +60.43%
Nov 14, 2024
Maintains: Buy
Price Target: $3
Current: $1.09
Upside: +175.23%
Aug 16, 2023
Maintains: Overweight
Price Target: $3 → $2
Current: $0.26
Upside: +682.47%
Mar 30, 2021
Initiates: Overweight
Price Target: $49
Current: $0.22
Upside: +22,182.61%